Tirzepatide emerges a groundbreaking therapeutic agent for individuals battling type 2 diabetes. As a dual agonist, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide https://iwancubm771994.aioblogs.com/93258611/tirzepatide-a-new-frontier-in-diabetes-treatment